A comprehensive clinical guide for Pneumocystis jirovecii pneumonia: a missing therapeutic target in HIV-uninfected patients.
Beisan A MohammadAbdullah Al-DulaimiMohammad AlkhatibMohammed Al MaqbaliMohammad A A Al-NajjarMamoon M D Al-RshaidatPublished in: Expert review of respiratory medicine (2022)
may worsen COVID-19's severity and fatality. PCP should be investigated in patients with PCP risk factors who come with pneumonia and suggestive radiographic symptoms but have not previously received PCP prophylaxis. PCP prophylaxis should be explored in individuals with various conditions that impair the immune system, depending on their PCP risk.
Keyphrases
- risk factors
- hiv infected
- end stage renal disease
- coronavirus disease
- ejection fraction
- sars cov
- newly diagnosed
- chronic kidney disease
- prognostic factors
- peritoneal dialysis
- hepatitis c virus
- human immunodeficiency virus
- hiv positive
- hiv testing
- hiv aids
- intensive care unit
- physical activity
- respiratory failure
- mass spectrometry
- depressive symptoms
- atomic force microscopy
- extracorporeal membrane oxygenation